Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

STIVARGA for Rectal cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where STIVARGA was used for Rectal cancer.

Most Reported Side Effects for STIVARGA

Side Effect Reports % Deaths Hosp.
Palmar-plantar erythrodysaesthesia syndrome 33 13.2% 9 14
Fatigue 27 10.8% 5 12
Pyrexia 27 10.8% 8 14
Diarrhoea 24 9.6% 6 12
Decreased appetite 23 9.2% 9 10
Dysphonia 23 9.2% 6 12
Hypertension 18 7.2% 5 8
Vomiting 18 7.2% 8 9
Colon cancer 17 6.8% 15 3
Nausea 16 6.4% 7 10
Hepatic function abnormal 15 6.0% 8 10
Colorectal cancer 14 5.6% 10 2
Rash 14 5.6% 5 9
Death 13 5.2% 13 6
Malaise 13 5.2% 6 9

Other Indications for STIVARGA

Colon cancer (68) Colorectal cancer (58) Colorectal cancer metastatic (25) Gastrointestinal stromal tumour (17) Colon cancer metastatic (9) Metastases to liver (7)

Other Drugs Used for Rectal cancer

CAPECITABINE (2,976) OXALIPLATIN (2,402) FLUOROURACIL (1,610) BEVACIZUMAB (1,546) TIPIRACIL\TRIFLURIDINE (1,297) IRINOTECAN (985) LEUCOVORIN (660) CETUXIMAB (542) REGORAFENIB (505) PANITUMUMAB (374)

Related Pages

STIVARGA Full Profile All Rectal cancer Drugs STIVARGA Demographics STIVARGA Timeline